Provided by Tiger Trade Technology Pte. Ltd.

InMed Pharmaceuticals Inc

0.6558
-0.0253-3.71%
Post-market: 0.6325-0.0233-3.55%19:25 EDT
Volume:145.99K
Turnover:92.88K
Market Cap:1.91M
PE:-0.23
High:0.6664
Open:0.6659
Low:0.5932
Close:0.6811
52wk High:7.98
52wk Low:0.5932
Shares:2.92M
Float Shares:1.48M
Volume Ratio:0.26
T/O Rate:9.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8800
EPS(LYR):-8.3630
ROE:-97.20%
ROA:-49.77%
PB:0.20
PE(LYR):-0.08

Loading ...

InMed Pharmaceuticals drops on Nasdaq notice; bid price stays below $1.00 for 30 straight sessions

Reuters
·
Yesterday

InMed Pharmaceuticals announces preclinical data on effects of INM-901

TIPRANKS
·
Mar 23

InMed Pharmaceuticals Inc - Announces Positive Data Supporting Inm-901 Alzheimer's Program - SEC Filing

THOMSON REUTERS
·
Mar 23

InMed Pharmaceuticals Inc - Targets Ind Submission and Phase 1 Clinical Trial for Inm-901 in 2027 - SEC Filing

THOMSON REUTERS
·
Mar 23

InMed reports INM-901 reduces IL-6 and IL-8 in human Alzheimer’s brain organoid models

Reuters
·
Mar 23

InMed Pharmaceuticals files $50M mixed securities shelf

TIPRANKS
·
Mar 21

InMed Pharmaceuticals provides development outlook for 2026

TIPRANKS
·
Mar 09

InMed targets 2027 Phase 1 trial start for INM-901 and plans FDA pre-IND meeting in Q3 2026

Reuters
·
Mar 09

InMed winds down BayMedica commercial operations to focus on drug development pipeline

Reuters
·
Mar 07

BRIEF-InMed Pharmaceuticals Inc - On March 4, Co Confirmed And Approved The Decision To Wind Down Baymedica's Commercial Operations - SEC Filing

Reuters
·
Mar 07

InMed Pharmaceuticals Inc - on March 4, Co Confirmed and Approved the Decision to Wind Down Baymedica's Commercial Operations - SEC Filing

THOMSON REUTERS
·
Mar 07

InMed pro forma net loss widens 18% to $8.83 million for FY2025

Reuters
·
Mar 07

InMed Pharmaceuticals Inc. Q2 BayMedica revenue drops 26% to USD 0.8 million

Reuters
·
Feb 12

InMed Pharma Q4 R&D expenses USD 0.63 million, down 30%

Reuters
·
Feb 12

InMed Pharmaceuticals Inc. Held Annual Shareholder Meeting

Reuters
·
Dec 18, 2025

ADVISORY-Dated alerts on InMed Pharmaceuticals withdrawn

Reuters
·
Dec 15, 2025

InMed Pharmaceuticals Inc - Expects Negative Impact on Baymedica From New Act H.r. 5371 - SEC Filing

THOMSON REUTERS
·
Dec 15, 2025

BayMedica Faces Uncertainty as New Law Threatens Commercial Operations

Reuters
·
Dec 15, 2025

Why Did Vivakor Shares Surge 17% After Hours?

Benzinga_recent_news
·
Nov 20, 2025

What's Driving InMed's (INM) 22% After-Hours Surge?

Benzinga
·
Nov 20, 2025